Supernus Pharmaceuticals Long Term Deferred Charges (Quarterly) Analysis

Supernus Pharmaceuticals, Inc. (SUPN)

51.24 +1.98 (+4.02%) USD | NASDAQ | Jan 07, 16:00

51.21 -0.03 (-0.06%) After-Hours: 04:48

View Long Term Deferred Charges (Quarterly) for SUPN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

BridgeBio Pharma, Inc.	--
The Cooper Cos., Inc.	--
Assembly Biosciences, Inc.	--
Amphastar Pharmaceuticals, Inc.	--
Viking Therapeutics, Inc.	--